South Africa is at the epicentre of the HIV and tuberculosis (TB) epidemics. The Clinical HIV Research Unit (CHRU) runs clinical trials undertaking clinical research to prevent, treat and manage HIV/AIDS, TB and associated diseases. It is a division of the Wits Health Consortium, a wholly owned company of the Faculty of Health Sciences at the University of Witwatersrand (Wits) located in Johannesburg, South Africa. It is affiliated to the Department of Internal Medicine at Wits. Our mission is to deliver excellence and quality in clinical research.
Our clinical trials focus on three main areas of intervention